ASP Isotopes Inc.: signs heads of agreement for HALEU joint venture

What happened

• On Oct 15, 2026, ASP Isotopes Inc. announced that a subsidiary of Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of the Company, signed a Heads of Agreement (the "Agreement") with the Nuclear Energy Corporation of South Africa SOC Limited ("Necsa").
• The Agreement establishes a binding commercial framework for a joint venture between QLE and Necsa to develop, finance, construct, commission, own, and operate a test bench and commercial-scale facility for the production of High-Assay Low-Enriched Uranium (HALEU) at Necsa's Pelindaba site in South Africa.

Key details

• Date of disclosure: Oct 15, 2026.
• Parties: a subsidiary of Quantum Leap Energy LLC (QLE) and the Nuclear Energy Corporation of South Africa SOC Limited (Necsa).
• Project scope: develop, finance, construct, commission, own, and operate a test bench and commercial-scale HALEU production facility at Pelindaba.
• The announcement was made via a press release included with the 8-K.

Why it may matter

• This report was filed under Item 7.01 (regulation FD disclosure), which covers public disclosure of the press release announcing the Agreement.
• A filing does not show why the insider traded or why the company acted.